SP
Santhera Pharmaceuticals Holding AG
SPHDF · OTC
$19.79 +0.00% (+$0.00)
Market Cap CHF 238.7M
P/E Ratio -
Div. Yield -
ROE 321.07%
Bulios Fair Price
$26.65
34.7% upside
Trenutna cena
$19.79
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SPHDF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
57 /100
Fair P/S 3.09x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 117.81%
EPS growth N/A
Book val. growth N/A
Profitability
5 /100
Weak Gross margin 18.74%
FCF margin 45.11%
Net margin 63.79%
Quality
6 /100
Poor ROIC 34.62%
Asset turnover 0.52x
ROE 321.07%
Debt
25 /100
High Current ratio 1.29x
Int. coverage -3.27x
Debt/Equity N/A
Stability
13 /100
Unstable Beta -0.28x
Profitable years 0
Rev. volatility 735.39%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SPHDF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Orlando Oliveira
Employees
78
Headquarters
Pratteln
Prihajajoči dogodki
21 SEP.
Earnings
Upcoming earnings report